vosoritide P2 第4コーホートの結果開示 / vosoritide P2 result of 4th cohort have been released

バイオリン社は、vosoritideフェーズ2における第4コーホートの結果をAmerican Society of Human Genetics 2016 Meeting(10月19日)において発表しました。


Biomarin announced the press release on 19th Oct.the result of 4th cohort of the phase 2 at the American Society of Human Genetics 2016 Meeting.Long story short, cohort 4 that is 30μg/kg is safe. But they did get higher result compare to third cohort that is 15μg/kg. So the they seems to decide to use 15μg for upcoming phase 3.


Refer to those LINKs, you can get good consideration with real data.

Beyond Achondroplasisa

Treating Achondroplasia